Shereshevsky-Turner syndrome: Estrogen replacement therapy and cardiovascular risk factors
Aim. To investigate the impact of menopausal hormone therapy (MHT) on the expression of risk factors for cardiovascular events (CVEs) in patients with Shereshevsky-Turner syndrome (STS); to elaborate an algorithm for patient management using MHT. Subjects and methods. From 2010 to 2012, a total of 4...
Main Authors: | O A Yevstigneeva, E N Andreeva, O R Grigoryan, N N Volevodz, G A Melnichenko, I I Dedov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2017-10-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/32312/pdf |
Similar Items
-
Psychosomatic disorders in people with Shereshevsky-Turner syndrome
by: M. A. Ryznychuk, et al.
Published: (2018-01-01) -
Psychosomatic disorders in people with Shereshevsky-Turner syndrome
by: M. A. Ryznychuk, et al.
Published: (2018-01-01) -
Psychosomatic disorders in people with Shereshevsky-Turner syndrome
by: M. A. Ryznychuk, et al.
Published: (2018-01-01) -
SHERESHEVSKY-TURNER SYNDROME IN AORTIC SURGERY: AN EXAMPLE OF HYBRID ANEURISM TREATMENT AND DISSECTION OF THORACOABDOMINAL AORTA
by: E. R. Tchartchan, et al.
Published: (2015-05-01) -
Pregnancy and childbirth with Shereshevsky–Turner syndrome, established at 12 years of age
by: Evgeny S. Mikhaylin, et al.
Published: (2020-12-01)